Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-21

Neuropeptides for treatment of rare lung diseases (primary and secondary pulmonary hypertension)

Objective

A joint effort of the coordinator and an applicant identified a group of peptides, which are beneficial to patients suffering from primary pulmonary hypertension and other lung disease leading to pulmonary hypertension. Our research demonstrated that these patients lack these peptides, while the receptors are over-expressed in the tissue. We showed the peptide to function on explanted animal and human tissue, and then developed an effective peptide substitution protocol via inhalation. Currently the first peptide is subject of clinical phase II testing. Substitution of bioactive peptides by inhalation is an innovative effective therapy for rare lung diseases. We will modify and optimise the peptide characteristics and go through the necessary pharmacological test phase II, to obtain a competitive and effective pharmaceutical product.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

DEM - Demonstration contracts

Coordinator

MEDICAL UNIVERSITY OF VIENNA
EU contribution
No data
Address
Spitalhgasse, 23
1090 WIEN
Austria

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (3)

My booklet 0 0